GLP-tox study reinforces favorable safety profile of Tiprelestat Phase II Study in Pulmonary Arterial Hypertension (PAH) to ...

The global medical equipment maintenance market is expected to grow at a compound annual growth rate (CAGR) of 8-10% over the ...

The global clinical trials market is anticipated to grow at a CAGR of 6-7% from 2024 to 2029. This growth is driven by the ...

Pharmaceutical REMS Market SizeThe global pharmaceutical REMS market — a critical safety framework for high‑risk drugs — is ...

"Inside the explosive rise of a wellness company outpacing a $200B+ global market"Watch the full Morning Show interview → ...

Study data suggests IGV-001 provides patients with a clinically meaningful improvement in overall survival (+6.3 months; +45%) compared to the current standard of care for ndGBM –– Company plans to ...

Egle Therapeutics SAS (Egle), a clinical-stage biotechnology company developing precision medicines that modulate regulatory T cells (Tregs) to restore immune balance, today announced dosing of the ...

US agreement removes U.S. tariffs on UK drugs but requires the NHS to pay more for new medicines by raising NICE thresholds ...

Tema ETFs (“Tema”), the New York-based manager of innovative exchange-traded funds (ETFs), is pleased to announce the Tema Oncology ETF (“CANC”) has surpassed $100m in assets under management (AUM) ...

UK-US deal is good news for NHS patients and will help to support UK life sciences competitiveness, says ABPI Industry hopes ...

This press release is provided in English and German.Xlife Sciences AG Delivers Breakthrough in Early Alzheimer’s Detection, Unlocking Major Market Opportunity ZURICH, Switzerland, December 01, ...

Lung Cancer Diagnostics Market OverviewThe global lung cancer diagnostics market is undergoing significant expansion as healthcare systems, technology developers, and research institutions intensify ...